Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | TACR1 | P25103 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7713293 | 0.81 | ALDH1A1 (0.40) | NPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL10676751 | 0.76 | NOTUM (0.36) | KDM4EALDH1A1TGFBR1 | |
| SCHEMBL7939506 | 0.76 | SIRT2 (0.40) | BACE1 | |
| SCHEMBL10917397 | 0.73 | NOTUM (0.39) | — | |
| SCHEMBL17651946 | 0.72 | MAPK1 (0.35) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL6170837 | 0.71 | BACE1 (0.32) | BACE1TACR1 | |
| SCHEMBL6971146 | 0.71 | KDM4E (0.37) | KDM4EALDH1A1MAPTSMN1; SMN2TGFBR1 | |
| SCHEMBL1097103 | 0.70 | SIRT2 (0.42) | BACE1TACR1MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL8022922 | 0.70 | NOTUM (0.36) | — | |
| SCHEMBL6967504 | 0.70 | TGFBR1 (0.32) | ALDH1A1MAPTTGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001017992-A1 | INHIBITORS OF PRENYL-PROTEIN TRANSFERASE | MERCK & CO., INC. (US) | 2001-03-15 | — | — | WO | disclosed |